Press release
Postmenopausal Osteoporosis Market Is Expected To Exhibit Significant Growth Over 2031
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/postmenopausal-osteoporosis-market
Changing lifestyle of people due to consumption of alcohol and smoking, mounting awareness among people through awareness initiatives and programs and continuous innovations in the drugs with the approval by the FDA creates the future opportunity for the growth of the market. On the other hand, there are various factors acting as the barriers for the market which includes the requirement of high standards for the approval of new product launch and increasing competition from the generics.
Global postmenopausal osteoporosis market can be segmented on the basis of treatment and distribution channel. Based on the treatment, the market can be further diversified as bisphosphonates, hormones, strontium ranelate, raloxifene and denosumab. Among the treatment, bisphosphonates segment is expected to lead the market as it is extensively used for the prevention and treatment of postmenopausal osteoporosis. Furthermore, on the basis of distribution channel, the market can be bifurcated as hospital pharmacies, retail pharmacies and E-commerce pharmacies.
Considering the geographical regions, the global Postmenopausal Osteoporosis market is divided into North America, Europe, Asia Pacific, and Rest of the world. The largest market share is covered by North America due to growing geriatric population, high level of developed technologies and healthcare spending. Europe is the region which covers significant market share due to increase in research and development and new product innovations. Asia Pacific considered as the fastest growing economy with the rising awareness among people, developing technologies and healthcare infrastructure.
The companies contributing to the global market includes Eli Lilly and company, Pfizer Inc., Proctor & Gamble Co., Amgen Inc., Novartis International AG, Allergan plc, Deltanoid Pharmaceuticals Inc., Novo- Nordisk A/S, and Phytohealth Corporation. The companies are entering into mergers and partnership in order to introduced new product innovation which in return enhance the market growth. For an instance: Radius Health, Inc. in April 2017, received FDA approval for TYMLOS (abaloparatide) injection to treat postmenopausal women with osteoporosis. TYMLOS in postmenopausal women with osteoporosis, reduce the risk of vertebral and nonvertebral fractures.
Postmenopausal Osteoporosis Market- Segmentation
By Treatment
• Bisphosphonates
• Hormones
• Strontium Ranelate
• Raloxifene
• Denosumab
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• E- Commerce Pharmacies
A full report of Postmenopausal Osteoporosis Market is available at: https://www.omrglobal.com/industry-reports/postmenopausal-osteoporosis-market
Postmenopausal Osteoporosis Market- Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Allergan Plc
• Amgen Inc.
• BiologicsMD, Inc.
• Deltanoid Pharmaceuticals Inc
• Eli Lilly and Company
• Enteris BioPharma, Inc.
• Hoffmann-La Roche AG
• GlaxoSmithKline plc.
• Ligand Pharmaceuticals Inc.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postmenopausal Osteoporosis Market Is Expected To Exhibit Significant Growth Over 2031 here
News-ID: 3494363 • Views: …
More Releases from Orion Market Research
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
Engineered Wood Adhesives Market is Likely to Increase at a Significantly High C …
The global engineered wood adhesives market is anticipated to grow at a CAGR of 19.0% during the forecast period (2024-2031). The market growth is attributed to the growing preference towards engineered wood products in furniture, and buildings, like plywood, and particleboard with increased demand as these products' construction requires reliable adhesives globally. There are numerous applications for engineered wood adhesives. Wood adhesive products are used to bind wood fibers, strands, and particles…
More Releases for Osteoporosis
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging populati …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot
Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of…
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022
The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%.
Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone…
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports.
For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews
February 03, 2017
Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
